Two women die from rare syndrome after AstraZeneca shot
The deaths from Guillain-Barre syndrome were consistent with being related to their COVID-19 vaccinations, an expert group has ruled
The TGA has confirmed the first Australian deaths from Guillain-Barré syndrome among patients who received AstraZeneca’s COVID-19 vaccine, Vaxzevria.
The two fatal cases of the rare immune disorder in the elderly women — a 77-year-old from Victoria and 81-year-old from NSW — bring the total deaths associated with the viral-vector vaccine to 11.
